Žabljak
Pretežno oblačno
4.3 °C
Pljevlja
Malo oblačno
-5.9 °C
Herceg Novi
Pretežno oblačno
7.7 °C
Nikšić
Pretežno oblačno
2.0 °C
Cetinje
Oblačno
1.5 °C
Bar
Oblačno
9.8 °C
Podgorica
Oblačno
7.2 °C
Ulcinj
Pretežno oblačno
8.0 °C
Kolašin
Pretežno oblačno
0.0 °C

We use cookies and google analytics tool to optimize the delivery of digital advertising to you. If you decline personalization of ads you will still see digital advertisements, but they will not be as relevant to you. We never collect sensitive information, and do not sell any of the data we collect. Under the GDPR regulations browser cookies are now considered sudo-anonymized personal data and since we use cookies to deliver relevant advertisements to you we would like to get your permission to do so.

I don't want my data to be used anymore for analytic purposes.

World

30. 12. 2020. 00:00   >>  17:10 0

SINOPHARM

China’s vaccine 79 percent protective against COVID-19

Chinese state-backed Sinopharm announced on Wednesday that its coronavirus vaccine is 79.34 percent effective against the virus, Reuters reported.

The news comes only weeks after the vaccine became officially available in the UAE.

Sinopharm subsidiary, and developer of the vaccine, China National Biotec Group (CNBG) has also filed for regulatory approval in China for its general public use, the group said on Wednesday.

It is one of the five most developed vaccine candidates from China including another from CNBG.

China’s emergency use program has vaccinated hundreds of thousands of people since July, and a Sinopharm vaccine was approved for emergency use in the UAE in September.

Phase III trials in the UAE involving around 31,000 volunteers suggested that its Sinopharm vaccine was 86 percent effective. The trials were run as a partnership between Sinopharm and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) and the Abu Dhabi Department of Health.

Komentari 0

ostavi komentar

Ostavi komentar

Pravila komentarisanja sadržaja Portala RTCG
Poštujući načelo demokratičnosti, kao i pravo građana da slobodno i kritički iznose mišljenje o pojavama, procesima, događajima i ličnostima, u cilju razvijanja kulture javnog dijaloga, na Portalu nijesu dozvoljeni komentari koji vrijeđaju dostojanstvo ličnosti ili sadrže prijetnje, govor mržnje, neprovjerene optužbe, kao i rasističke poruke. Nijesu dozvoljeni ni komentari kojima se narušava nacionalna, vjerska i rodna ravnopravnost ili podstiče mržnja prema LGBT populaciji. Neće biti objavljeni ni komentari pisani velikim slovima i obimni "copy/paste" sadrzaji knjiga i publikacija.Zadržavamo pravo kraćenja komentara.

Da biste komentarisali vijesti pod vašim imenom

Ulogujte se

Novo